Research ExplorerPublicationsClassical hodgkin lymphoma as de novo B-cell malignancy afte...

Classical hodgkin lymphoma as de novo B-cell malignancy after treatment of multiple myeloma in the pre-lenalidomide era

Standard

Classical hodgkin lymphoma as de novo B-cell malignancy after treatment of multiple myeloma in the pre-lenalidomide era. / Zago, Manola; Adam, Patrick; Goldschmidt, Hartmut; Fend, Falko; Kanz, Lothar; Weisel, Katja.

In: CL LYMPH MYELOM LEUK, Vol. 14, No. 1, 02.2014, p. e7-e11.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Zago, M, Adam, P, Goldschmidt, H, Fend, F, Kanz, L & Weisel, K 2014, 'Classical hodgkin lymphoma as de novo B-cell malignancy after treatment of multiple myeloma in the pre-lenalidomide era', CL LYMPH MYELOM LEUK, vol. 14, no. 1, pp. e7-e11. https://doi.org/10.1016/j.clml.2013.07.101

APA

Zago, M., Adam, P., Goldschmidt, H., Fend, F., Kanz, L., & Weisel, K. (2014). Classical hodgkin lymphoma as de novo B-cell malignancy after treatment of multiple myeloma in the pre-lenalidomide era. CL LYMPH MYELOM LEUK, 14(1), e7-e11. https://doi.org/10.1016/j.clml.2013.07.101

Vancouver

Zago M, Adam P, Goldschmidt H, Fend F, Kanz L, Weisel K. Classical hodgkin lymphoma as de novo B-cell malignancy after treatment of multiple myeloma in the pre-lenalidomide era. CL LYMPH MYELOM LEUK. 2014 Feb;14(1):e7-e11. https://doi.org/10.1016/j.clml.2013.07.101

Bibtex

@article{345d997ec5a146069acf6a3c0e0774b3,
title = "Classical hodgkin lymphoma as de novo B-cell malignancy after treatment of multiple myeloma in the pre-lenalidomide era",
keywords = "B-Lymphocytes, Female, Hodgkin Disease, Humans, Immunologic Factors, Lenalidomide, Middle Aged, Multiple Myeloma, Thalidomide, Case Reports, Journal Article",
author = "Manola Zago and Patrick Adam and Hartmut Goldschmidt and Falko Fend and Lothar Kanz and Katja Weisel",
year = "2014",
month = feb,
doi = "10.1016/j.clml.2013.07.101",
language = "English",
volume = "14",
pages = "e7--e11",
journal = "CL LYMPH MYELOM LEUK",
issn = "2152-2650",
publisher = "Cancer Media Group",
number = "1",

}

RIS

TY - JOUR

T1 - Classical hodgkin lymphoma as de novo B-cell malignancy after treatment of multiple myeloma in the pre-lenalidomide era

AU - Zago, Manola

AU - Adam, Patrick

AU - Goldschmidt, Hartmut

AU - Fend, Falko

AU - Kanz, Lothar

AU - Weisel, Katja

PY - 2014/2

Y1 - 2014/2

KW - B-Lymphocytes

KW - Female

KW - Hodgkin Disease

KW - Humans

KW - Immunologic Factors

KW - Lenalidomide

KW - Middle Aged

KW - Multiple Myeloma

KW - Thalidomide

KW - Case Reports

KW - Journal Article

U2 - 10.1016/j.clml.2013.07.101

DO - 10.1016/j.clml.2013.07.101

M3 - SCORING: Journal article

C2 - 24169269

VL - 14

SP - e7-e11

JO - CL LYMPH MYELOM LEUK

JF - CL LYMPH MYELOM LEUK

SN - 2152-2650

IS - 1

ER -